59 related articles for article (PubMed ID: 18952065)
1. A new evaluation method for quantifying PI3K activity by HTRF assay.
Sugita H; Dan S; Kong D; Tomida A; Yamori T
Biochem Biophys Res Commun; 2008 Dec; 377(3):941-5. PubMed ID: 18952065
[TBL] [Abstract][Full Text] [Related]
2. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.
Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L
Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460
[TBL] [Abstract][Full Text] [Related]
3. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.
Huang CH; Mandelker D; Schmidt-Kittler O; Samuels Y; Velculescu VE; Kinzler KW; Vogelstein B; Gabelli SB; Amzel LM
Science; 2007 Dec; 318(5857):1744-8. PubMed ID: 18079394
[TBL] [Abstract][Full Text] [Related]
4. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
Riener MO; Bawohl M; Clavien PA; Jochum W
Genes Chromosomes Cancer; 2008 May; 47(5):363-7. PubMed ID: 18181165
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic PI3K deregulates transcription and translation.
Bader AG; Kang S; Zhao L; Vogt PK
Nat Rev Cancer; 2005 Dec; 5(12):921-9. PubMed ID: 16341083
[TBL] [Abstract][Full Text] [Related]
6. Functional differences between two classes of oncogenic mutation in the PIK3CA gene.
Chaussade C; Cho K; Mawson C; Rewcastle GW; Shepherd PR
Biochem Biophys Res Commun; 2009 Apr; 381(4):577-81. PubMed ID: 19233141
[TBL] [Abstract][Full Text] [Related]
7. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.
Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L
Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the utility of the HTRF Transcreener ADP assay technology: a comparison with the standard HTRF assay technology.
Hong L; Quinn CM; Jia Y
Anal Biochem; 2009 Aug; 391(1):31-8. PubMed ID: 19406097
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific mutations in phosphatidylinositol 3-kinase.
Vogt PK; Kang S; Elsliger MA; Gymnopoulos M
Trends Biochem Sci; 2007 Jul; 32(7):342-9. PubMed ID: 17561399
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE
Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
12. A separation-free assay for the detection of mutations: combination of homogeneous time-resolved fluorescence and minisequencing.
Lopez-Crapez E; Bazin H; Chevalier J; Trinquet E; Grenier J; Mathis G
Hum Mutat; 2005 May; 25(5):468-75. PubMed ID: 15832307
[TBL] [Abstract][Full Text] [Related]
13. p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity.
Chaudhari A; Krumlinde D; Lundqvist A; Akyürek LM; Bandaru S; Skålén K; Ståhlman M; Borén J; Wettergren Y; Ejeskär K; Rotter Sopasakis V
Mol Cell Biol; 2015 Oct; 35(19):3258-73. PubMed ID: 26169833
[TBL] [Abstract][Full Text] [Related]
14. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
[TBL] [Abstract][Full Text] [Related]
15. Visualization of Ras-PI3K interaction in the endosome using BiFC.
Tsutsumi K; Fujioka Y; Tsuda M; Kawaguchi H; Ohba Y
Cell Signal; 2009 Nov; 21(11):1672-9. PubMed ID: 19616621
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
17. Polyunsaturated fatty acids inhibit PI3K activity in a yeast-based model system.
Couplan E; Le Cann M; Le Foll C; Corporeau C; Blondel M; Delarue J
Biotechnol J; 2009 Aug; 4(8):1190-7. PubMed ID: 19557793
[TBL] [Abstract][Full Text] [Related]
18. Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K).
Kalsi N; Gopalakrishnan C; Rajendran V; Purohit R
J Biomol Struct Dyn; 2016 Dec; 34(12):2711-2721. PubMed ID: 26646651
[TBL] [Abstract][Full Text] [Related]
19. PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role.
Utsugi M; Dobashi K; Ono A; Ishizuka T; Matsuzaki S; Hisada T; Shimizu Y; Kawata T; Aoki H; Kamide Y; Mori M
J Immunol; 2009 May; 182(9):5225-31. PubMed ID: 19380768
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα.
Liu X; Zhou Q; Hart JR; Xu Y; Yang S; Yang D; Vogt PK; Wang MW
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2215621119. PubMed ID: 36343266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
